Judy Lieberman

Judy Lieberman is an Endowed Chair in Cellular and Molecular Medicine and Senior Investigator at the Program in Cellular and Molecular Medicine at Boston Children's Hospital. She is also a Professor of Pediatrics and Adjunct Professor of Genetics at Harvard Medical School. Her research spans immunology, cell biology, and cancer research, with a focus on understanding the molecular mechanisms of immune responses to infection and cancer.

Dr. Lieberman earned her undergraduate degree from Radcliffe College, followed by a Ph.D. in physics from Rockefeller University. She worked as a high-energy physicist at the prestigious Institute for Advanced Study in Princeton before earning her M.D. from the joint Harvard-MIT Program in Health, Science, and Technology. She completed her clinical training in internal medicine and hematology-oncology at Tufts Medical Center and was a postdoctoral fellow in immunology at MIT.

Her research has made groundbreaking contributions to our understanding of cytotoxic T lymphocytes, cell death mechanisms, and immune responses. Key areas of focus include:

• Mechanisms of granzyme-mediated cell death, including the discovery of caspase-independent programmed cell death pathways
• Pyroptosis and gasdermin proteins in immunity and disease
• RNA interference and its therapeutic applications
• Immune responses to viral infections, particularly HIV
• Cancer immunology and tumor microenvironment

Analysis of Dr. Lieberman's recent publications (2020-2024) reveals a strong focus on gasdermin proteins and pyroptosis in various disease contexts. Her work has elucidated how gasdermins function in tumor immunity, neurodegeneration, and infectious diseases. There's also significant work on how tumors evade immune recognition and potential strategies to reverse this process. Her research bridges basic science with therapeutic applications, particularly in cancer immunotherapy.

Dr. Lieberman's scientific achievements have been recognized with election to the American Academy of Arts and Sciences in 2008. Her work has significantly advanced our understanding of immune cell function and cell death mechanisms.

Dr. Lieberman has mentored numerous students and postdoctoral fellows throughout her career, as evidenced by her extensive list of alumni. Her laboratory at Boston Children's Hospital is a hub for innovative research at the intersection of immunology, cell biology, and disease mechanisms. The lab has received substantial funding for research on immune responses, cell death mechanisms, and therapeutic applications.

The Lieberman Laboratory is part of the Program in Cellular and Molecular Medicine at Boston Children's Hospital and maintains strong affiliations with Harvard Medical School programs in Immunology, Genetics, and the Harvard Stem Cell Institute. The lab continues to make significant contributions to understanding the molecular basis of immune responses and developing novel therapeutic approaches.